Moilec (Meloxicam)

Meloxicam works by selectively blocking the COX‑2 enzyme, which reduces the production of prostaglandins—chemical mediators that cause inflammation, pain, and fever. This selective inhibition provides anti‑inflammatory and analgesic effects while sparing COX‑1 activity to a greater extent.

The appropriate dose of Moilec is determined by the prescribing clinician based on the patient’s condition, severity, and overall health status. Dosage regimens are individualized and should follow the prescriber’s instructions.

Safety of meloxicam in pregnancy or lactation has not been definitively established. It should be used only if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To request Moilec, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Compared with non‑selective NSAIDs such as ibuprofen, meloxicam offers greater COX‑2 selectivity, which may reduce gastrointestinal irritation. However, it shares similar cardiovascular and renal risk profiles with other NSAIDs, and choice of therapy should consider individual patient risk factors.

Moilec should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the product away from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Moilec is taken orally, usually with a full glass of water. It may be taken with or without food, but taking it with food can help minimise gastrointestinal discomfort.

Serious risks include gastrointestinal ulceration or bleeding, cardiovascular events such as heart attack or stroke, renal impairment, severe skin reactions, and hepatic injury. Patients should be monitored for signs of these conditions and seek medical attention promptly if they occur.

Moilec is contraindicated in patients with known hypersensitivity to meloxicam or other NSAIDs, those with active gastrointestinal bleeding or ulceration, severe heart failure, and in individuals who have had a recent coronary artery bypass graft. Caution is also advised for patients with impaired renal or hepatic function.